Mirum Pharmaceuticals (MIRM) EPS (Basic) (2019 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly EPS (Basic) of -$13.43 for Q1 2026, down 4372.32% year-over-year from $0.31 in Q1 2025, and down 11662.31% quarter-over-quarter from -$0.11 in Q4 2025.
Powered by 
Analysis
Mirum Pharmaceuticals (MIRM) EPS (Basic) (2019 - 2026) Analysis & Trends
Mirum Pharmaceuticals' EPS (Basic) history runs 8 years deep, the most recent figure standing at -$13.43 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 4372.32% year-over-year to -$13.43; the TTM figure through Mar 2026 stood at -$13.57 (down 758.05% YoY), while the FY2025 annual figure was -$0.47, up 74.85% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$13.43, down from -$0.11 in the prior quarter.
- The five-year high for EPS (Basic) was $0.06 in Q3 2025, with the low at -$13.43 in Q1 2026.
- The 5-year median for EPS (Basic) is -$0.57 (2023), against an average of -$1.41.
- The sharpest annual moves came in 2025 and 2026: EPS (Basic) surged 119.26% in 2025, then tumbled 4372.32% in 2026.
- Mirum Pharmaceuticals' EPS (Basic) stood at -$1.08 in 2022, then rose by 18.99% to -$0.87 in 2023, then jumped by 42.6% to -$0.5 in 2024, then jumped by 77.2% to -$0.11 in 2025, then sank by 11662.31% to -$13.43 in 2026.
- Business Quant data shows MIRM's EPS (Basic) at -$13.43 in Q1 2026, -$0.11 in Q4 2025, and $0.06 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Mirum Pharmaceuticals | 6.40 Bn | 5.96 Bn | 145.90 Mn | -1.06 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.06 |
| Mar 31, 2026 | -13.43 |
| Dec 31, 2025 | -0.11 |
| Sep 30, 2025 | 0.06 |
| Jun 30, 2025 | -0.12 |
| Mar 31, 2025 | -0.30 |
| Dec 31, 2024 | -0.50 |
| Sep 30, 2024 | -0.30 |
| Jun 30, 2024 | -0.52 |
| Mar 31, 2024 | -0.54 |
| Dec 31, 2023 | -0.87 |
| Sep 30, 2023 | -0.57 |
| Jun 30, 2023 | -1.94 |
| Mar 31, 2023 | -0.80 |
| Dec 31, 2022 | -1.08 |
| Sep 30, 2022 | -1.02 |
| Jun 30, 2022 | -0.84 |
| Mar 31, 2022 | -1.17 |
| Dec 31, 2021 | 1.89 |
| Sep 30, 2021 | -1.55 |